MSN Group is the fastest growing research-based pharmaceutical company based out of India. Founded in 2003 with a mission to make health care affordable, this Hyderabad-based venture has nine API and five finished dosage facilities established across Hyderabad, USA and Myanmar.

Candidates with 2 - 7 years of experience in Sterile, OSD & Oncology in tormulations shall walk in to the following career enabling opportunities at Hyderabad.

Sai Life Sciences is one of India’s fastest growing Contract Research, Development & Manufacturing Organizations. As a pure-play, full-service CRO-CDMO, we work with over a 150 global innovator pharma and biotech companies to accelerate the discovery, development, and commercialisation of their NCE small molecule programmes.

Walk-in-interview for Quality Assurance (QA) roles in our manufacturing unit, Bidar

Founded in 1849, Pfizer is the worlds premier biopharmaceutical company taking new approaches to better health. We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support.

ICMR-NARI is located at Bhosari, Pune on a seven acre plot. Since its inception the Institute has ably supported the National AIDS Control Programme, especially in the areas of surveillance, capacity building, laboratory services and drug resistance studies. ICMR-NARI derives strength from wide ranging National and International Collaborations.  The Institute's research activities are guided by a Scientific Advisory Committee which includes eminent scientists from varied disciplines.

Micro Labs Limited is a multi-faceted healthcare organization with a proficient marketing team, state-of-the-art manufacturing facilities and R&D centres that are at par with international standards. All this, robustly backed by a strong distribution network and path-breaking research work has placed us amongst India’s fast growing transnational healthcare organizations.

For QC Department - ML01 (Hosur) & ML31 (Bommasandra)

Autoimmune diseases are thought to be the result of mistaken identity. Immune cells on patrol, armed and ready to defend the body against invading pathogens, mistake normal human cells for infected cells and turn their weapons on their own healthy tissues. In most cases, though, finding the source of the confusion the tiny fragment of normal human protein that looks dangerously similar to a protein from a pathogen  has been challenging for scientists.

Besides the skin, the digestive tract is the tissue that is most exposed to environmental influences such as bacteria and viruses. Therefore, cells that form these barriers to the interior of the body also have special defence mechanisms. A research team led by Professor Dr Thorsten Hoppe has now shown that RNA interference, or RNAi for short, which is known to be a viral defence mechanism, also prevents the overproduction of the body’s own proteins in intestinal cells.

Nizam's Institute of Medical Sciences, formerly Nizams Orthopaedic Hospital, is a public hospital located in Hyderabad, Telangana, India. It is an Institute under State Legislature Act under the Act of Andhra Pradesh State Legislature. It has campuses in Punjagutta and Bibinagar.

Post : Project Assistant

Tata Consultancy Services is an Indian multinational information technology services and consulting company headquartered in Mumbai. It is a part of the Tata Group and operates in 149 locations across 46 countries.

Post : DM / LDM / SDTL (Study Data Team Lead) / Non CRF DM

Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, is a Super-Speciality teaching and training Medical Institution, situated to the Southeast of Lucknow city on Lucknow-Raebareli Road, and is nearly 12 Km from the main (Charbagh) railway station, Lucknow Airport and city center (Hazratganj). From the railway station, private buses (route 3) run to the Institute at short intervals. Alternatively, pre-paid auto-rickshaws taxis are also available for travel to the Institute.

CSIR - Indian Institute of Chemical Technology, Hyderabad is a Premier Research Laboratory under the Council of Scientific and Industrial Research , which is an autonomous body under the Ministry of Science & Technology, Government of India. CSIR-IICT is a multi-disciplinary Institute with proven strengths in Organic Chemistry (drugs, agro chemicals and industrial organics), Inorganic and Physical Chemistry including Catalysis, Lipid Science & Technology, Organic Coatings & Polymers, Chemical Biology, Chemical Engineering and Design Engineering.

National Health Mission Tamil Nadu (NHM-TN) is the umbrella programme of the Ministry of Health & Family Welfare, Government of India to assure universal access to equitable, affordable and quality health care which is accountable and at the same time responsive to the needs of the people and works towards reduction of child and maternal deaths as well as population stabilization, gender equity and demographic balance.

Post : State Consultant – Public Health

Fidelity Health Services are frontline adopters in technology-based solutions for our clients. By combining high-end Technologies with skilled human resources & smart processes, our pharmaceuticals, biopharma & life sciences clients are effectively advancing discoveries, and are delivering solutions that make a difference in patients’ lives.

Post : Senior Executive, Medical Knowledge Management

Legacy of Alembic Pharmaceuticals Limited (APL) dates back to over 100 years. Established in 1907 with an objective to develop and revolutionize the Pharmaceutical and Drug industry in the Indian subcontinent, Alembic Pharmaceuticals Limited today is one of the leading pharmaceutical companies in India.

Position : Senior Product Manager / Group Product Manager-Veterinary

Lupin Diagnostics Limited is a 100% subsidiary of Lupin Limited. The company is headquartered in Mumbai with National Reference Laboratory in Navi Mumbai. All the processing laboratories are operated by Lupin Diagnostics as a hub and spoke model. It includes Collection Centres, Pick-up Points, Hospital Laboratory Management, Retail Laboratory Management, and Home Collection pan-India.

Post : Officer / Jr. Officer (Analyst) - Quality Control

Hetero Drugs is an Indian pharmaceutical company and the world’s largest producer of anti-retroviral drugs. Hetero’s business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics. Globally renowned, vertically integrated pharmaceutical player engaged in Research and Development (R&D), manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas.

HETERO – Walk-In Interview for FRESHERS QA / QC  on 14th Dec’ 2022 at Hyderabad

Stallion Headquartered in Ahmedabad (India) along with three Overseas offices in Vietnam, Nigeria and Angola for its international operations.  Stallion manufactures a wide range of pharmaceuticals, across the broad spectrum of therapies which includes Antidiabetics, Cardiovascular, Urology, Antibiotics – Antibacterial, Gastrointestinal, Cough & Cold, Anxiolytics & Antidepressants, Analgesics –Anti-Inflammatories, Antivirals, Antifungals, Anthelminthic, Anti protozoal, Antimalarial, Antihistaminic, Nutritional supplements and others.

Incorporated in 1996, SIRO Clinpharm Private Limited is a Clinical Research Organisation supporting trials from Phase II to Phase IV and beyond post-launch of products. SIRO offers a range of services, from clinical operations to data services, data analytics and medical writing in compliance with international standards.   SIRO has been an industry pioneer over two decades, sharing an incontestable record of excellence in the pharmaceutical, FMCG and medical device industry.

A small molecule inhibitor that attacks the difficult to target, cancer-causing gene mutation KRAS, found in nearly 30 percent of all human tumors, successfully shrunk tumors or stopped cancer growth in preclinical models of pancreatic cancer, researchers from Penn Medicine’s Abramson Cancer Center showed, suggesting the drug is a strong candidate for clinical trials. The study was published today in Cancer Discovery, a journal of the American Association for Cancer Research.